Skip to main content
. 2025 Aug 27;17(17):2806. doi: 10.3390/cancers17172806
AJCC American Joint Committee on Cancer
ALT alanine aminotransferase
AST aspartate aminotransferase
CI confidence interval
CRP C-reactive protein
CTCAE Common Terminology Criteria for Adverse Events
CTLA-4 cytotoxic T-lymphocyte-associated protein-4
CXCL chemokine (C-X-C motif) ligand
ECOG Eastern Cooperative Oncology
HR hazard ratio
ICI immune checkpoint inhibition
IQR interquartile range
irAE immune-related adverse events
LDH lactate dehydrogenase
LoD limit of detection
NA Not applicable
NLR neutrophil-to-lymphocyte ratio
OS overall survival
PD progressive disease
PD-1 programmed cell death protein-1
PFS progression-free survival
RECIST Response Evaluation Criteria in Solid Tumors
SD standard deviation
SITC Society for Immunotherapy of Cancer
Th T-helper lymphocytes
TNF-α tumor necrosis factor alpha